RARE
Ultragenyx
14.50$
-1.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +182.7% | -3.4% | -9.2% | +46.6% | +57.8% | +55.0% | -13.5% | +1.5% | -3.5% | +0.8% | +1.9% | |
| – | +140.1% | +10.6% | -50.9% | +113.7% | +62.9% | +52.2% | -33.9% | +3.2% | -17.2% | +11.6% | +16.4% | |
| – | +284.7% | +72.2% | -37.6% | +12.9% | +282.2% | +64.6% | -56.9% | -56.8% | +60.7% | -18.7% | +149.8% | |
| – | +133.1% | +14.0% | -50.9% | +88.0% | +64.3% | +59.1% | -38.4% | +1.0% | -22.8% | +5.7% | +13.6% | |
| – | – | – | – | +146.3% | +157.8% | -29.7% | +92.4% | -9.0% | +81.5% | +66.0% | +30.5% | |
| – | – | – | – | +833.3% | +63.4% | +13.0% | +24.4% | +64.9% | +26.9% | +32.5% | +15.5% | |
| – | +143.1% | +131.3% | +28.0% | -8.2% | +272.5% | -1.6% | +92.1% | +83.9% | – | – | – | |
| – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -0.9% | |
| – | – | – | – | -8.7% | -0.2% | +1.6% | -0.2% | +22.4% | +3.9% | +7.2% | -1.3% | |
| – | +118.7% | +134.0% | +61.0% | +3.1% | +335.4% | +25.6% | -0.9% | +98.9% | +1.9% | +2.1% | +29.3% | |
| – | +123.0% | +115.8% | +17.8% | +5.2% | +38.2% | +83.6% | -4.3% | +44.0% | +7.4% | +22.7% | +11.6% | |
| – | – | – | – | – | – | +24.1% | +23.3% | +6.4% | +6.9% | -18.2% | +686.6% | |
| – | -39.4% | +82.3% | +65.7% | +38.1% | +4.9% | +0.4% | +32.6% | +152.5% | -2.7% | -8.0% | -20.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +187.2% | -10.8% | -19.1% | +58.8% | +7.4% | +76.6% | -20.1% | -61.8% | -21.9% | -7.3% | -131.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +27.9% | +7.6% | +7.2% | +17.2% | +13.7% | +7.5% | +11.4% | +3.1% | +5.2% | +23.1% | +8.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.